Article · 29 Aug 2026
Conference abstractPublished 28 May 2021
Development of strategies for battle against COVID-19 (a mini-project)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Despite of the key importance the immunity, the activated immune reaction, including by vaccines, could cause unwished effects, for instance in cases as allergies, auto-immune diseases and disorders, as well as cardio-vascular pathologies. Toxic side effects of the chemical anti-viral preparations should also be taken in consideration. So, the main goal is connected with suppression of the cellular penetration and/or replication of COVID-19, both in vitro and in vivo, by RNA-interference of respective viral genes with appropriate siRNAs. Methodology & Theoretical Orientation: In vitro-incubated cells should be inoculated with viral strain with RNA-genome (if is possible, belonging to Coronaviridae family), which should then be treated with appropriate siRNAs against genes in the viral RNA-genome, necessary about viral penetration in the cell and/or viral replication. Subsequent evaluation on the in vivo-influence of the tested siRNAs on appropriate experimental animals, infected with the same RNA-viral strain, should further be performed. Findings & Perspectives: Besides suppression of the virus penetration in the cell and/or its replication, adequate immunity should be supported. Possibility for production of antibodies and membrane receptor glycoproteins by non-lymphoid and non-myeloid cellular types. Because the so produced immunoglobulins/ antibodies are out of the germinative centers, their functions should be controlled by low-molecular mass molecules as gangliosides. Further intra- and extra-cellular interactions between different biological molecules (protein-protein, protein-RNA, protein-DNA, protein-lipid, protein-carbohydrate, DNA-DNA, DNARNA, RNA-RNA, DNA-DNA, etc.), underlining these processes, should be performed. CRISPR/Cas systems as universal mechanisms, responsible about normal/non-malignant cellular differentiation, adequate immune reaction, but also of cellular ageing and death, should be investigated. Conclusion & Significance: After performance of all steps described, evaluation on the in vivo-influence of the tested siRNAs on patients/volunteers with COVID-19 (in the first 24-48 hours post infection) could be performed. PDF HTML
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Iskra V Sainova”